CCC
THCX

Crescent Capital Consulting’s AXS Cannabis ETF THCX Stock Holding History

Crescent Capital Consulting’s Portfolio THCX Stock Details THCX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		$0 Hold
2
– – ﹤0.01% 525
2021
Q3 		$0 Sell
2
-1
-33% -$147 ﹤0.01% 608
2021
Q2 		$1K Hold
3
– – ﹤0.01% 485
2021
Q1 		$1K Buy
+3
New +$588 ﹤0.01% 488

Other funds holding THCX

Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
Wealthfront Advisers
Wealthfront Advisers Palo Alto, California $45.6B AUM 18.83% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $71.6B AUM 21.08% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return
AIA
Alera Investment Advisors Deerfield, Illinois $851M AUM 29.76% 1-Year Est. Return
PP
Peconic Partners New York $5.78B AUM 127.23% 1-Year Est. Return
MML Investors Services
MML Investors Services Springfield, Massachusetts $36.1B AUM 19.68% 1-Year Est. Return
3LCM
3D/L Capital Management Hartford, Connecticut $308M AUM 13.67% 1-Year Est. Return
SWP
ShoreHaven Wealth Partners Red Bank, New Jersey $318M AUM 24.89% 1-Year Est. Return

Crescent Capital Consulting's THCX Position: Q4 2021 in Review

Crescent Capital Consulting held its AXS Cannabis ETF (THCX) position steady in Q4 2021 at 2 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #525.

Crescent Capital Consulting first reported a position in THCX in Q1 2021 and has held it in 4 quarters since. The position peaked at $1K in Q2 2021. 44 funds tracked by Wall St. Rank hold THCX as of Q4 2021.

  • Crescent Capital Consulting held 2 shares of AXS Cannabis ETF worth $0 as of Q4 2021.
  • Crescent Capital Consulting left its AXS Cannabis ETF share count unchanged in Q4 2021.
  • AXS Cannabis ETF made up ﹤0.01% of Crescent Capital Consulting's portfolio in Q4 2021, its #525 holding.
  • Crescent Capital Consulting first reported a position in AXS Cannabis ETF in Q1 2021 and has held it in 4 quarters since.
  • Crescent Capital Consulting's AXS Cannabis ETF position peaked at $1K in Q2 2021.
  • 44 funds tracked by Wall St. Rank held AXS Cannabis ETF as of Q4 2021.

Based on Crescent Capital Consulting's 13F filing for Q4 2021, filed 18 Jan 2022.